MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2025-04-30, ENZB made $6,402K in revenue. -$2,790K in net income. Net profit margin of -43.58%.

Income Overview

Revenue
$6,402K
Net Income
-$2,790K
Net Profit Margin
-43.58%
EPS
-$0.05
Unit: Thousand (K) dollars
Revenue Breakdown
    • US
    • Europe
    • Asia Pacific

Unit: Thousand (K) dollars (except for numbers of shares and EPS)
Income Statement
2025-04-30
Revenues
6,402
Selling, general and administrative
4,904
Research and development
504
Legal and related expense, net
465
Cost of revenues
3,755
Cost of revenues inventory provision
163
Total operating costs and expenses
9,791
Operating loss
-3,389
Other
123
Interest, net
384
Foreign exchange (loss) gain
508
Total other income (expense), net
1,015
Loss before income taxes
-2,374
Net loss from continuing operations
-2,374
Net loss from discontinued operations
-416
Net loss
-2,790
Total net loss per basic and diluted common share (in dollars per share)
-0.05
Total net loss per diluted common share (in dollars per share)
-0.05
Basic (in shares)
52,403
Diluted (in shares)
52,403
Unit: Thousand (K) dollars (except for numbers of shares and EPS)

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

DownloadDownload image
Net loss-$2,790K Net loss fromdiscontinued operations-$416K Net loss fromcontinuing operations-$2,374K Foreign exchange (loss)gain$508K Interest, net$384K Other$123K Loss before incometaxes-$2,374K Total other income(expense), net$1,015K US$4,054K Asia Pacific$642K Europe$1,706K Operating loss-$3,389K Revenues$6,402K Total operating costsand expenses$9,791K Cost of revenues inventory provision$163K Cost of revenues$3,755K Legal and relatedexpense, net$465K Research and development$504K Selling, general andadministrative$4,904K

ENZO BIOCHEM INC (ENZB)

ENZO BIOCHEM INC (ENZB)